Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A checking system for injectable anticancer drugs using each patient's own data and its evaluation].

Yasuaki Ohtsubo1, Keizo Ishimito, Momoe Tanioka

  • 1Department of Pharmacy, Yamaguchi University Hospital, 1-1-1 Minamikogushi, Ube 755-8505, Japan. bookston-ygc@umin.ac.jp

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|June 29, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive assessment of on- and off-target mutagenesis via lipid nanoparticle delivery of CRISPR-Cas9 genome editing.

Molecular therapy. Nucleic acids·2026
Same author

Muscle satellite cell editing by LNP-CRISPR-Cas9 to resist muscle injury.

Cell reports·2025
Same author

Author Correction: Brain tumors induce widespread disruption of calvarial bone and alteration of skull marrow immune landscape.

Nature neuroscience·2025
Same author

Brain tumors induce widespread disruption of calvarial bone and alteration of skull marrow immune landscape.

Nature neuroscience·2025
Same author

Bjerkandera adusta Fungi as Causative Agent of Invasive Chronic Rhinosinusitis.

Emerging infectious diseases·2025
Same author

Elimination of the extra chromosome of Dup15q syndrome iPSCs for cellular and molecular investigation.

European journal of cell biology·2024

A new system enhances injectable anticancer drug safety by providing real-time prescription checks and automated preparation calculations. This risk management tool significantly reduces medication errors and preparation time for pharmacists.

Area of Science:

  • Oncology
  • Pharmacology
  • Health Informatics

Context:

  • Injectable anticancer drug use presents complex challenges in dosage and administration.
  • Pharmacists face difficulties in verifying prescriptions and ensuring aseptic intravenous (IV) admixing.
  • Existing methods are time-consuming and prone to errors.

Purpose:

  • To develop and evaluate a checking system for risk management of injectable anticancer drug use.
  • To provide real-time verification of dosage, infusion rates, and dosing schedules.
  • To streamline the aseptic IV admixing process and enhance patient safety.

Summary:

  • The system performs real-time checks using patient-specific data (height, weight, BSA, medical history, ICD10 code) and drug information.
  • It automatically calculates liquid volumes for admixing, lists stability times, and incorporates clinical laboratory results.

Related Experiment Videos

  • The system identified 24 medication errors and 13 contraindications before administration in its first six months.

    • Impact:

    • Prevented medication errors including incorrect doses and inappropriate dosing intervals.
    • Reduced aseptic IV admixing preparation time by 73%.
    • Enabled advance identification of patients for whom the drug is contraindicated, improving rational drug use and risk management.